Envestnet Asset Management Inc. Lowers Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Envestnet Asset Management Inc. decreased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 672,389 shares of the medical device company's stock after selling 31,048 shares during the period. Envestnet Asset Management Inc. owned 0.34% of Cooper Companies worth $61,813,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Captrust Financial Advisors increased its stake in Cooper Companies by 9.7% during the third quarter. Captrust Financial Advisors now owns 3,816 shares of the medical device company's stock worth $421,000 after acquiring an additional 338 shares during the last quarter. HighTower Advisors LLC raised its stake in shares of Cooper Companies by 11.7% in the third quarter. HighTower Advisors LLC now owns 20,506 shares of the medical device company's stock valued at $2,261,000 after acquiring an additional 2,155 shares during the period. MML Investors Services LLC boosted its stake in shares of Cooper Companies by 1.6% during the 3rd quarter. MML Investors Services LLC now owns 17,787 shares of the medical device company's stock worth $1,963,000 after purchasing an additional 280 shares during the period. Nomura Asset Management Co. Ltd. lifted its stake in Cooper Companies by 8.1% in the third quarter. Nomura Asset Management Co. Ltd. now owns 58,703 shares of the medical device company's stock worth $6,477,000 after purchasing an additional 4,408 shares during the last quarter. Finally, Barclays PLC lifted its stake in shares of Cooper Companies by 0.7% during the 3rd quarter. Barclays PLC now owns 462,947 shares of the medical device company's stock worth $51,082,000 after acquiring an additional 3,070 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

Several research firms have recently weighed in on COO. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Piper Sandler reissued an "overweight" rating and set a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. JPMorgan Chase & Co. dropped their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Citigroup decreased their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Stock Performance

COO traded down $0.77 on Tuesday, reaching $77.99. 292,901 shares of the stock were exchanged, compared to its average volume of 1,393,757. The Cooper Companies, Inc. has a fifty-two week low of $69.81 and a fifty-two week high of $112.38. The firm has a market capitalization of $15.60 billion, a PE ratio of 40.01, a PEG ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company's 50-day moving average price is $84.28 and its 200 day moving average price is $94.31.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.